Literature DB >> 16741215

Increased number of subcortical hyperintensities on MRI in children and adolescents with Tourette's syndrome, obsessive-compulsive disorder, and attention deficit hyperactivity disorder.

Jose A Amat1, Richard A Bronen, Sanjay Saluja, Noriko Sato, Hongtu Zhu, Daniel A Gorman, Jason Royal, Bradley S Peterson.   

Abstract

OBJECTIVE: To investigate whether cerebral hyperintensities on T2-weighted magnetic resonance images (MRI) are associated with childhood neuropsychiatric disorders.
METHOD: The authors compared the frequency of cortical and subcortical cerebral hyperintensities in 100 children and adolescents with Tourette's syndrome, obsessive-compulsive disorder (OCD), or attention deficit hyperactivity disorder (ADHD) and 32 healthy comparison subjects.
RESULTS: The frequency of cerebral hyperintensities was significantly higher in subjects with Tourette's syndrome, OCD, or ADHD than in healthy comparison subjects; each diagnostic group seemed to contribute to this effect. Among the patient groups, the likelihood of detecting cerebral hyperintensities in the subcortex (primarily the basal ganglia and thalamus) was significantly greater than in the cortex.
CONCLUSIONS: A childhood diagnosis of Tourette's syndrome, OCD, or ADHD significantly increased the likelihood of detecting cerebral hyperintensities, particularly in the subcortex, supporting the notion that subcortical injury may play a role in the pathophysiology of these conditions.

Entities:  

Mesh:

Year:  2006        PMID: 16741215      PMCID: PMC2367225          DOI: 10.1176/ajp.2006.163.6.1106

Source DB:  PubMed          Journal:  Am J Psychiatry        ISSN: 0002-953X            Impact factor:   18.112


  6 in total

1.  Sydenham chorea: MR manifestations in two cases.

Authors:  G D Kienzle; R K Breger; R W Chun; M L Zupanc; J F Sackett
Journal:  AJNR Am J Neuroradiol       Date:  1991 Jan-Feb       Impact factor: 3.825

2.  Sydenham's chorea: magnetic resonance imaging of the basal ganglia.

Authors:  J N Giedd; J L Rapoport; M J Kruesi; C Parker; M B Schapiro; A J Allen; H L Leonard; D Kaysen; D P Dickstein; W L Marsh
Journal:  Neurology       Date:  1995-12       Impact factor: 9.910

3.  Preliminary findings of antistreptococcal antibody titers and basal ganglia volumes in tic, obsessive-compulsive, and attention deficit/hyperactivity disorders.

Authors:  B S Peterson; J F Leckman; D Tucker; L Scahill; L Staib; H Zhang; R King; D J Cohen; J C Gore; P Lombroso
Journal:  Arch Gen Psychiatry       Date:  2000-04

4.  Magnetic resonance imaging white matter hyperintensities and mechanism of ischemic stroke.

Authors:  R Mäntylä; H J Aronen; O Salonen; T Pohjasvaara; M Korpelainen; T Peltonen; C G Standertskjöld-Nordenstam; M Kaste; T Erkinjuntti
Journal:  Stroke       Date:  1999-10       Impact factor: 7.914

5.  CNS vasculitis in autoimmune disease: MR imaging findings and correlation with angiography.

Authors:  M G Pomper; T J Miller; J H Stone; W C Tidmore; D B Hellmann
Journal:  AJNR Am J Neuroradiol       Date:  1999-01       Impact factor: 3.825

6.  White matter hyperintensities on magnetic resonance imaging of the brain in children with psychiatric disorders.

Authors:  In Kyoon Lyoo; Ho Kyu Lee; Ji Hyun Jung; Gil G Noam; Perry F Renshaw
Journal:  Compr Psychiatry       Date:  2002 Sep-Oct       Impact factor: 3.735

  6 in total
  13 in total

1.  Neural substrates of impaired sensorimotor timing in adult attention-deficit/hyperactivity disorder.

Authors:  Eve M Valera; Rebecca M C Spencer; Thomas A Zeffiro; Nikos Makris; Thomas J Spencer; Stephen V Faraone; Joseph Biederman; Larry J Seidman
Journal:  Biol Psychiatry       Date:  2010-08-15       Impact factor: 13.382

2.  PANDAS and comorbid Kleine-Levin syndrome.

Authors:  Diana M Gerardi; Joseph Casadonte; Priyal Patel; Tanya K Murphy
Journal:  J Child Adolesc Psychopharmacol       Date:  2014-10-20       Impact factor: 2.576

Review 3.  Genetics of obsessive-compulsive disorder and related disorders.

Authors:  Heidi A Browne; Shannon L Gair; Jeremiah M Scharf; Dorothy E Grice
Journal:  Psychiatr Clin North Am       Date:  2014-07-23

4.  Atypical Functional Connectivity in Tourette Syndrome Differs Between Children and Adults.

Authors:  Ashley N Nielsen; Caterina Gratton; Jessica A Church; Nico U F Dosenbach; Kevin J Black; Steven E Petersen; Bradley L Schlaggar; Deanna J Greene
Journal:  Biol Psychiatry       Date:  2019-07-02       Impact factor: 13.382

5.  The familial association of tourette's disorder and ADHD: the impact of OCD symptoms.

Authors:  Julia A O'Rourke; Jeremiah M Scharf; Jill Platko; S Evelyn Stewart; Cornelia Illmann; Daniel A Geller; Robert A King; James F Leckman; David L Pauls
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2011-05-06       Impact factor: 3.568

6.  Structural abnormalities in the substantia nigra and neighbouring nuclei in Tourette's syndrome.

Authors:  Guadalupe Dávila; Marcelo L Berthier; Jaime Kulisevsky; Beatriz Asenjo; Jorge Gómez; J Pablo Lara; Salud Jurado Chacón; Víctor M Campos
Journal:  J Neural Transm (Vienna)       Date:  2010-02-04       Impact factor: 3.575

Review 7.  Brain imaging in pediatric obsessive-compulsive disorder.

Authors:  Frank P MacMaster; Joseph O'Neill; David R Rosenberg
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  2008-11       Impact factor: 8.829

8.  Latent class analysis of gilles de la tourette syndrome using comorbidities: clinical and genetic implications.

Authors:  Marco A Grados; Carol A Mathews
Journal:  Biol Psychiatry       Date:  2008-03-21       Impact factor: 13.382

Review 9.  Imaging evidence for anatomical disturbances and neuroplastic compensation in persons with Tourette syndrome.

Authors:  Kerstin J Plessen; Ravi Bansal; Bradley S Peterson
Journal:  J Psychosom Res       Date:  2009-10-14       Impact factor: 3.006

10.  Altered monocyte activation markers in Tourette's syndrome: a case-control study.

Authors:  Judith Matz; Daniela L Krause; Sandra Dehning; Michael Riedel; Rudolf Gruber; Markus J Schwarz; Norbert Müller
Journal:  BMC Psychiatry       Date:  2012-05-18       Impact factor: 3.630

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.